China Medical Technologies, which produces in-vitro diagnostic products and tumor-treating, high-intensity focused ultrasound systems, reported very sharp increases for its full-year 2007 financial results, which ended on March 31, 2008. Revenues jumped 67% to $130.6 million. Net income (non-GAAP) rose 39% to $61.6 million, a 47% profit margin, and equal to $2.20 per share. China Medical said that its results exceeded expectations. More details...

Stock Symbol: (NSDQ: CMED)